Literature DB >> 1884775

Epidemiology of rickettsial diseases.

D H Walker1, D B Fishbein.   

Abstract

Rickettsial diseases have a diversity of epidemiologic characteristics reflective of the variety of ecologic situations in which the obligate intracellular bacteria are transmitted to humans. For the spotted fever group (SFG) rickettsiae, Rickettsia typhi, R. tsutsugamushi, Coxiella burnetii, and the human ehrlichial agent, humans are a dead-end host who plays no role in the maintenance of the organism in nature. All rickettsioses exist as zoonoses. Moreover, all rickettsiae are found in infected arthopods, which generally serve as the natural hosts and can transmit the infection to the next generation of ticks, mites, chiggers, or fleas. From our anthropocentric viewpoint, Q fever aerosol infection from parturient animals and Brill-Zinsser disease ignited epidemics of louse-borne epidemic typhus are exceptions. However, silent cycles of C. burnetii in ticks and R. prowazekii in the flying squirrel flea may have maintained these agents in transovarial or enzootic cycles for eons before humans and their domestic animals arrived on the scene. Thus, the epidemiology of rickettsial diseases must be recognized as an unfortunate aberration of the rickettsial economy. Several excellent reviews of rickettsial ecology contain a wealth of useful information.

Entities:  

Mesh:

Year:  1991        PMID: 1884775     DOI: 10.1007/bf00145672

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  90 in total

1.  Surveillance of human ehrlichiosis in the United States: 1988.

Authors:  T R Eng; D B Fishbein; J E Dawson; C R Greene; M Redus
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

2.  Isolation of spotted fever group rickettsiae from humans in Japan.

Authors:  T Uchida; T Uchiyama; A H Koyama
Journal:  J Infect Dis       Date:  1988-09       Impact factor: 5.226

3.  Rickettsial antibody in southern France: antibodies to Rickettsia conorii and Coxiella burnetii among urban, suburban and semi-rural blood donors.

Authors:  D Raoult; B Toga; H Chaudet; C Chiche-Portiche
Journal:  Trans R Soc Trop Med Hyg       Date:  1987       Impact factor: 2.184

4.  Israeli rickettsial spotted fever in children. A review of 54 cases.

Authors:  E M Gross; P Yagupsky
Journal:  Acta Trop       Date:  1987-03       Impact factor: 3.112

5.  Rocky Mountain spotted fever: clinical, laboratory, and epidemiological features of 262 cases.

Authors:  C G Helmick; K W Bernard; L J D'Angelo
Journal:  J Infect Dis       Date:  1984-10       Impact factor: 5.226

6.  Occurrence of Rocky Mountain spotted fever in relation to climatic, geophysical, and ecologic variables.

Authors:  J E Kaplan; V F Newhouse
Journal:  Am J Trop Med Hyg       Date:  1984-11       Impact factor: 2.345

7.  Febrile illness in Malaysia--an analysis of 1,629 hospitalized patients.

Authors:  G W Brown; A Shirai; M Jegathesan; D S Burke; J C Twartz; J P Saunders; D L Huxsoll
Journal:  Am J Trop Med Hyg       Date:  1984-03       Impact factor: 2.345

8.  Documented Rocky Mountain spotted fever in Wintertime.

Authors:  J V Lange; D H Walker; T B Wester
Journal:  JAMA       Date:  1982-05-07       Impact factor: 56.272

9.  Q fever in the Basque Country: 1981-1984.

Authors:  M Montejo Baranda; J Corral Carranceja; C Aguirre Errasti
Journal:  Rev Infect Dis       Date:  1985 Sep-Oct

10.  Epidemiology of Rocky Mountain spotted fever as determined by active surveillance.

Authors:  C M Wilfert; J N MacCormack; K Kleeman; R N Philip; E Austin; V Dickinson; L Turner
Journal:  J Infect Dis       Date:  1984-10       Impact factor: 5.226

View more
  27 in total

1.  Prevalence of antibodies to spotted fever group rickettsiae in the region of Split (southern Croatia).

Authors:  Volga Punda-Polić; Zorana Klismanić; Vesna Capkun
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

2.  Reemerging threat of epidemic typhus in Algeria.

Authors:  K Mokrani; P E Fournier; M Dalichaouche; S Tebbal; A Aouati; D Raoult
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

3.  Rickettsia infection in natural leech populations.

Authors:  Y Kikuchi; T Fukatsu
Journal:  Microb Ecol       Date:  2005-06-17       Impact factor: 4.552

4.  Spotted fever group Rickettsiae in ticks in Cyprus.

Authors:  Dimosthenis Chochlakis; Ioannis Ioannou; Vassilios Sandalakis; Theodoros Dimitriou; Nikolaos Kassinis; Byron Papadopoulos; Yannis Tselentis; Anna Psaroulaki
Journal:  Microb Ecol       Date:  2011-08-11       Impact factor: 4.552

5.  Growth of Coxiella burnetii in the Ixodes scapularis-derived IDE8 tick cell line.

Authors:  Brian Herrin; Saugata Mahapatra; Edmour F Blouin; Edward I Shaw
Journal:  Vector Borne Zoonotic Dis       Date:  2011-01-22       Impact factor: 2.133

Review 6.  Laboratory diagnosis of rickettsioses: current approaches to diagnosis of old and new rickettsial diseases.

Authors:  B La Scola; D Raoult
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

7.  Proteolytic Cleavage of the Immunodominant Outer Membrane Protein rOmpA in Rickettsia rickettsii.

Authors:  Nicholas F Noriea; Tina R Clark; David Mead; Ted Hackstadt
Journal:  J Bacteriol       Date:  2017-02-28       Impact factor: 3.490

8.  Spotted fever group Rickettsia in ticks from southeastern Spain natural parks.

Authors:  Francisco J Márquez
Journal:  Exp Appl Acarol       Date:  2008-08-02       Impact factor: 2.132

9.  Rickettsia parkeri infection after tick bite, Virginia.

Authors:  Timothy J Whitman; Allen L Richards; Christopher D Paddock; Cindy L Tamminga; Patrick J Sniezek; Ju Jiang; David K Byers; John W Sanders
Journal:  Emerg Infect Dis       Date:  2007-02       Impact factor: 6.883

10.  Fatal spotted fever rickettsiosis, Minas Gerais, Brazil.

Authors:  Márcio Antonio Moreira Galvâo; J Stephen Dumler; Cláudio Lísias Mafra; Simone Berger Calic; Chequer Buffe Chamone; Gracco Cesarino Filho; Juan Pablo Olano; David H Walker
Journal:  Emerg Infect Dis       Date:  2003-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.